Based in Vancouver, we are a leading Canadian biopharmaceutical company that utilizes therapeutic and proprietary compounds to increase the effectiveness and reduce the side-effects of established and novel anti-cancer therapies.
The company’s lead product, ONCO TCS, is currently in the final stages of human clinical testing as a treatment for non-Hodgkin’s lymphoma. ONCO TCS is also in development for small cell lung cancer and pediatric cancers. In addition to ONCO TCS, Inex has a pipeline of other products in clinical and pre-clinical testing for various types of cancer.
Inex Pharmaceuticals Corp. does not currently have any available jobs.